Completed PHASE4 INTERVENTIONAL 3-arm NCT00160173

Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy

Efficacy Study Comparing 0.9 g and 1.25 g EstroGelÂ® 0.03% Doses With Placebo in the Treatment of Vasomotor Symptoms and Vulvar and Vaginal Atrophy Associated With Menopause

Sponsor: ASCEND Therapeutics

Conditions Postmenopausal Symptoms

Interventions Estrogel Placebo

Updated 8 times since 2017 Last updated: Sep 8, 2022 Started: Dec 2, 2004 Primary completion: Sep 6, 2005 Completion: Sep 6, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Postmenopausal Symptoms and is currently completed. ASCEND Therapeutics leads this study, which shows 8 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Sep 2022 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Sep 2022 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Dec 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ASCEND Therapeutics
Solvay Pharmaceuticals

Data source: ASCEND Therapeutics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Alpharetta, United States , Ann Arbor, United States , Atlanta, United States , Aventura, United States , Avon, United States , Baltimore, United States , Baton Rouge, United States , Billings, United States , Birmingham, United States , Boise, United States and 71 more locations